Smad3 knockout significantly alleviates renal fibrosis in models of obstructive nephropathy, DKD, and other diseases, and TGF-β1 can inhibit the activity of antioxidant enzymes to mediate the occurrence of Smad3-dependent renal fibrosis [42]. Here, SMAD3 is linked to diabetic kidney disease.